Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2024 Earnings Call Transcript March 31, 2025
Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.61, expectations were $-0.66.
Operator: Welcome to the conference call hosted by Daré Bioscience to review the company’s 2024 Financial Results and to provide a Business Update. This call is being recorded. My name is Jericho, and I’ll be your operator today. With us today from Daré are Sabrina Martucci Johnson, President and Chief...
